产品详情
Targets
Target | Value |
---|---|
EGFR | IC50: 2nM |
HER2/ErbB2 | IC50: 6nM |
c-Abl | IC50: 52nM |
FLT1 | IC50: 59nM |
c-Fms | IC50: 60nM |
c-Src | IC50: 61nM |
KDR | IC50: 77nM |
HER4/ErbB4 | IC50: 160nM |
PDGFRβ | IC50: 320nM |
FLT4 | IC50: 330nM |
FLT3 | IC50: 730nM |
RET | IC50: 740nM |
c-Kit | IC50: 790nM |
Tek | IC50: 2.1μM |
C-Raf-1 | IC50: 2.8μM |
c-Met | IC50: 2.9μM |
CDK1/CyclinB | IC50: 8.0μM |
IGF-1R | IC50: >10μM |
Insulin Receptor | IC50: >10μM |
PKCα | IC50: >10μM |
PKA | IC50: >10μM |
In vitro (25°C) | DMSO | 81 mg/mL (183.84 mM) | |
Water | Insoluble | ||
Ethanol | Insoluble | ||
In vivo | 30% PEG400+0.5% Tween80+5% propylene glycol | 28 mg/mL | |
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.1 mM | 22.7 mL | 113.48 mL | 226.96 mL |
0.5 mM | 4.54 mL | 22.7 mL | 45.39 mL |
1 mM | 2.27 mL | 11.35 mL | 22.7 mL |
5 mM | 0.45 mL | 2.27 mL | 4.54 mL |
*The above data is based on the productmolecular weight 440.6 . Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
目录号 | A10043 |
---|---|
作用机制 | Inhibitor (抑制剂) |
M. Wt | 440.6 |
Formula | C27H32N6 |
Purity | >99% |
Storage | Store lyophilized at -20ºC, keep desiccated. |
CAS No. | 497839-62-0 |
Synonyms | AEE-788, NVP-AEE788 |
SMILES | CCN1CCN(CC1)CC2=CC=C(C=C2)C3=CC4=C(N3)N=CN=C4N[C@H](C)C5=CC=CC=C5 |
产品标签
Product Questions
Product Questions
Icotinib Hydrochloride
Icotinib hydrochloride是一种有效的特异性表皮生长因子受体(EGFR)酪氨酸激酶抑制剂(TKI),IC(50)为5 nM,…
Neratinib (HKI-272)
Neratinib (HKI-272)是一种酪氨酸激酶抑制剂。
Mubritinib (TAK 165)
Mubritinib (TAK 165)是一种有效的EGFR和p34cdc2抑制剂,IC50分别为6 nM和0.2 ?M。Mubritinib(TAK 165)也抑制p33cdk2和p33cd…
AG-18 (Tyrphostin 23)
AG-18 (Tyrphostin 23)是人表皮癌细胞系A431中的表皮生长因子(EGF)受体激酶抑制剂,IC50值为35M。
ARRY-543 (Varlitinib, ASLAN001)
ARRY-543 (Varlitinib,ASLAN001)是一种新型口服ErbB家族抑制剂,与批准的ErbB抑制剂不同,它直接或间接靶向ErbB家…
PF299804 (Dacomitinib, PF299)
PF299804是一种有效的,可口服的酪氨酸激酶人表皮生长因子受体(HER)1(EGFR),HER2和HER4不可逆抑制剂。